Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase

Programmable gene integration in human cells has the potential to enable mutation-agnostic treatments for loss-of-function genetic diseases and facilitate many applications in the life sciences. CRISPR-associated transposases (CASTs) catalyze RNA-guided DNA integration but thus far demonstrate minimal activity in human cells. Using phage-assisted continuous evolution (PACE), we generated CAST variants with >200-fold average improved integration activity. The evolved CAST system (evoCAST) achieves ~10 to 30% integration efficiencies of kilobase-size DNA cargoes in human cells across 14 tested genomic target sites, including safe harbor loci, sites used for immunotherapy, and genes implicated in loss-of-function diseases, with undetected indels and low levels of off-target integration. Collectively, our findings establish a platform for the laboratory evolution of CASTs and advance a versatile system for programmable gene integration in living systems.

Authors

Institutions

Publication Details

Journal
Science
Published
2025-05-15
DOI
https://doi.org/10.1126/science.adt5199
Citations
52
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
41.91
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase

Phuc Leo H. Vo, Rebeca T. King, Albert T. Chen, Mark J. Osborn et al.
52 citations
Science
CRISPR and Genetic Engineering
41.91
article

Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase

Phuc Leo H. Vo, Rebeca T. King, Albert T. Chen, Mark J. Osborn, Shannon M. Miller, George D. Lampe, Simon Eitzinger, Isaac P. Witte, Kiara N. Berríos, Jakub Tolar, David R. Liu, Samuel H. Sternberg, Amber McElroy, Diego R. Gelsinger, Olivia G. Stringham
article en
52 citations

Abstract

Programmable gene integration in human cells has the potential to enable mutation-agnostic treatments for loss-of-function genetic diseases and facilitate many applications in the life sciences. CRISPR-associated transposases (CASTs) catalyze RNA-guided DNA integration but thus far demonstrate minimal activity in human cells. Using phage-assisted continuous evolution (PACE), we generated CAST variants with >200-fold average improved integration activity. The evolved CAST system (evoCAST) achieves ~10 to 30% integration efficiencies of kilobase-size DNA cargoes in human cells across 14 tested genomic target sites, including safe harbor loci, sites used for immunotherapy, and genes implicated in loss-of-function diseases, with undetected indels and low levels of off-target integration. Collectively, our findings establish a platform for the laboratory evolution of CASTs and advance a versatile system for programmable gene integration in living systems.

ScienceVol. 388(6748)
Broad Institute (US), Howard Hughes Medical Institute (US), Harvard University (US), University of Minnesota Medical Center (US), Columbia University (US)
Openalex Percentile: Top 0%
CRISPR and Genetic Engineering
41.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.